Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing

06-Jun-2023 - Waters Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics. Software and hardware integrations between the Waters™ PATROL™ ...

Cancer: Tumor transition states

23-Apr-2018 - Researchers at the Université libre de Bruxelles, ULB define for the first time the tumor transition states occurring during cancer progression and identify the tumor cell populations responsible for metastasis. Tumor heterogeneity describes the differences between different cells within a given ...

Agilent Technologies scientist wins Young Investigator Award

19-Feb-2016 - Agilent Technologies Inc. announced that the Chinese American Chromatography Association has honored Xiaoli Wang, Ph.D., with its Young Investigator Award. Dr. Wang is an Agilent scientist who has been instrumental in extending the company’s Poroshell 120 technology into biopharmaceutical columns ...

Neutron beams reveal how antibodies cluster in solution

23-May-2014 - Scientists have used small-angle neutron scattering (SANS) and neutron spin-echo (NSE) techniques for the first time to understand how monoclonal antibodies (mAbs), a class of targeted biopharmaceuticals used to treat autoimmune disorders and cancer, dynamically cluster and move in high ...

Drug developers rawn to orphan drugs market

Breakthrough therapies for rare diseases command premium pricing, particularly if no alternatives exist

31-Mar-2014 - The global orphan drugs market presents plenty of opportunities for new drug development – while there are only 172 approved orphan therapies, over 6,800 orphan diseases exist according to the United States National Institute of Health (NIH). Advancements in drug discovery capabilities coupled ...

Molecular robots can help researchers build more targeted therapeutics

Study demonstrates technique to create better anti-cancer agents, arthritis drugs, and more

31-Jul-2013 - Many drugs such as agents for cancer or autoimmune diseases have nasty side effects because while they kill disease-causing cells, they also affect healthy cells. Now a new study has demonstrated a technique for developing more targeted drugs, by using molecular "robots" to hone in on more ...

Dako and Epitomics enter into strategic alliance on developing and launching IHC diagnostic monoclonal antibodies

23-Mar-2011 - Dako Denmark A/S and Epitomics, Inc. announced that they have entered into a collaboration which will allow the companies to unite competencies to provide the Anatomic Pathology market with state-of-the-art antibodies.Dako's expertise within the field of human cancer diagnostics, including ...

BioSystem Development and BAC BV collaborate to bring purification ligands to high throughput biotherapeutic process development

08-Nov-2010 - BioSystem Development and BAC BV announced a collaboration to bring state-of-the-art high affinity ligands to the AssayMAP high-throughput micro-chromatography platform. This collaboration marks an essential objective toward growing a family of high-throughput tools for micro-scale purification ...

Top Pharmaceutical and Biotech companies face slow down in sales growth over 2008–14

01-Mar-2010 - Top pharmaceutical and biotech companies face a major slow down in sales growth over 2008–14 according to a new report by independent business analyst Datamonitor. The report title “Pharmaceutical Company Outlook to 2014” considers the forecast performance of the world’s biggest pharmaceutical ...

NattoPharma acquires MGP Diagnostics and secures rights to important patent

16-Oct-2008 - NattoPharma ASA has acquired all shares of MGP Diagnostics AS, securing ownership of a granted patent that is the key to the development of a new diagnostic test concept. This concept may determine the need for the natural vitamin K2 product Mena Q7(TM), to which NattoPharma has exclusive ...